Crystal Arthropathies: Clinical Trials

5 trials for Crystal Arthropathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Completed 4, Terminated 1

Follow Crystal Arthropathies: new trials by email Literature Review of Crystal Arthropathies trials Research Report on Crystal Arthropathies

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects
LC350189 200mg, Placebo, Moxifloxacin 400mg - Hyperuricemia, Gout
Early Phase 1CompletedLG Chem372021-09-232022-01-06
COVID-19 Vaccination in Rheumatic Disease Patients
mRNA COVD19 vaccine - Systemic Lupus Erythematosus, Sjogren's Syndrome
Early Phase 1TerminatedMayo Clinic582021-02-152022-06-03
Effect of Probenecid on Synovial Fluid ATP Levels in CPPD
Probenecid - Calcium Pyrophosphate Deposition Disease
Early Phase 1CompletedVA Office of Research and Development82014-10-152022-07-26
Apolipoprotein CIII Reduction Via Colchicine
Colchicine - Hypertriglyceridemia, Gout
Early Phase 1CompletedScripps Translational Science Institute52014-02-012014-05-30
Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial
Treatment, Control - Hyperuricemia, Gout
Early Phase 1CompletedUniversity of Leeds222013-02-012015-03-24

Narrower conditions

Gout (4)  ·  Hyperuricemia (2)  ·  Arthritis, Psoriatic (1)  ·  Cardiovascular Diseases (1)  ·  Chondrocalcinosis (1)  ·  Diabetes Mellitus (1)  ·  Disease (1)  ·  Hypertriglyceridemia (1)  ·  Kidney Calculi (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Osteoarthritis (1)  ·  Pericarditis (1)  ·  Sjogren's Syndrome (1)  ·  Spondylitis, Ankylosing (1)

Broader conditions

Arthritis (5)  ·  Joint Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Metabolic Diseases (4)  ·  Metabolism, Inborn Errors (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Purine-Pyrimidine Metabolism, Inborn Errors (4)  ·  Rheumatic Diseases (4)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Ankylosis (1)  ·  Arthritis, Rheumatoid (1)

Interventions

Colchicine (1)  ·  Moxifloxacin (1)  ·  Probenecid (1)  ·  Tablets (1)  ·  Therapeutics (1)  ·  Uricosuric Agents (1)

Sponsors

LG Chem (1)  ·  Mayo Clinic (1)  ·  Scripps Translational Science Institute (1)  ·  University of Leeds (1)  ·  VA Office of Research and Development (1)

Countries

United States (4)  ·  United Kingdom (1)

Top investigators

Ann K Rosenthal, MD (1)  ·  Gary Williamson, PhD (1)  ·  Hu Zeng, PhD (1)  ·  Peter Schultz, PhD (1)  ·  Yuanlu Shi, PhD Candidate (1)

NIH funding

1UL1TR001114-01 (1)